Artelo Biosciences, Inc. announced the termination of a Securities Purchase Agreement and a Consulting Agreement on August 19, 2025, nullifying previous agreements and obligations. The agreements involved the return of any received funds to investors, alongside the forfeiture of consulting rights, with no termination penalties applicable.